MUC1 and pancreatic neoplasm: Since the pancreatic cancer cells used in this study have high, albeit heterogeneous, MUC16 expression, in addition to heterogeneous MUC1 expression (Figure 1), we wanted to investigate the immune shielding effect of MUC1 and MUC16 in regard to ADCC.